S-ICD® System IDE Clinical Study

Status Active, not recruiting

Clinical Trial Summary

This clinical study is designed to evaluate the safety and effectiveness of the subcutaneous implantable defibrillator (S-ICD) System.

Clinical Trial Description

This clinical study is a prospective, non-randomized, multicenter clinical study without a control group conducted in the United States, Europe, and New Zealand.

Patients meeting eligibility criteria for implanting an S-ICD System will be enrolled in this clinical study, implanted with an S-ICD System, and followed prior to hospital discharge, and post-implant at 30 days, 90 days, and 180 days. After the 180-day post-implant follow-up visit, patients will continue to be followed semi-annually until study closure.

Eligible patients enrolled in this clinical study may also participate in the chronic conversion sub-study.

The safety endpoint will be evaluated through the use of a 180-day S-ICD System complication-free rate. The effectiveness endpoint will be evaluated using an induced ventricular fibrillation (VF) conversion efficacy rate. Spontaneous episodes and chronic conversion testing data will be evaluated using descriptive statistics to provide additional data supporting the continued chronic performance of the S-ICD System. ;

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01064076
Study type	Interventional
Source	Boston Scientific Corporation
Contact
Status	Active, not recruiting
Phase	N/A
Start date	January 2010
Completion date	October 2013

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01546207` - Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia	N/A
Completed	`NCT04070300` - Physical Activity and Ventricular Arrhythmias	N/A
Completed	`NCT04075253` - Acute Effect of One Single Bout of High Intensity Exercise on the Tendency for Ventricular Arrhythmia	N/A
Completed	`NCT00000531` - Antiarrhythmics Versus Implantable Defibrillators (AVID)	Phase 3
Completed	`NCT00000480` - Multicenter Unsustained Tachycardia Trial (MUSTT)	Phase 3
Completed	`NCT05086510` - Ablation Targets of Scar-related Ventricular Tachycardia Identified by Dynamic Functional Substrate Mapping	N/A
Completed	`NCT01940081` - The Leiden Nonischemic Cardiomyopathy Study
Recruiting	`NCT01222156` - Accuracy and Safety Study of the Magnetecs CGCI System for Intracardiac Mapping	Phase 1/Phase 2
Terminated	`NCT00749671` - Bispectral Index Monitoring During Testing in the Electrophysiology Lab	N/A
Recruiting	`NCT00385749` - Right Ventricular Defibrillation Lead Select Site Study	N/A
Completed	`NCT00382928` - Automatic External Defibrillation Monitoring in Cardiac Arrest	Phase 1
Completed	`NCT00279279` - PREPARE - Primary Prevention Parameters Evaluation	N/A
Terminated	`NCT00776087` - European Health Economic Trial on Home Monitoring in ICD and CRT-D Patients (EuroEco)	N/A
Withdrawn	`NCT00510731` - The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events	N/A
Completed	`NCT01572246` - Effects of Monopolar Electrocautery Use During Surgery on Implanted Cardiac Defibrillators	N/A
Completed	`NCT00170287` - SMS: Substrate Modification Study in Patients Getting an Implantable Cardioverter Defibrillator (ICD)	Phase 4
Completed	`NCT00147277` - ADVANCE-D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy	Phase 4
Completed	`NCT00004559` - Fatty Acid Antiarrhythmia Trial (FAAT)	Phase 3
Completed	`NCT00702117` - Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias	Phase 4
Completed	`NCT00232297` - Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS	Phase 2